Work

Erythropoiesis-Stimulating Agent Use Among Non–Dialysis-Dependent CKD Patients Before and After the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Using a Large US Health Plan Database

Year: 2014

Type: article

Study design: Observational Study

Source: American Journal of Kidney Diseases

DOI: 10.1053/j.ajkd.2014.05.013

Authors: Mae Thamer, Yi Zhang, Onkar Kshirsagar, Dennis J. Cotter, James S. Kaufman

Institutions: Medical Technology and Practice Patterns Institute, VA NY Harbor Healthcare System, New York University

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institute of Diabetes and Digestive and Kidney Diseases

Award: Erythropoiesis-stimulating agent use among chronic kidney disease patients

OpenAlex ID: W2022953798

FWCI: 1.182

Cites: 24

Cited by: 15

Related to: 10